VALYSTR · Stock research
Listed on NasdaqCM. What the market is pricing into ImmuCell Corporation (ICCC) in the Healthcare sector: implied growth, valuation scenarios, SEC-filed financials, and what has moved the stock.
Healthcare · In Vitro & In Vivo Diagnostic Substances · market value about $93.1M · P/E 146.4 · revenue $30.7M (as of 2026-11-04)
Opening the full page… All companies · Research guides · What a reverse DCF shows